Epana Bio
Berkeley
About Epana Bio
Epana Bio is pioneering precision therapies for autoimmune diseases by targeting root cellular dysfunction. Leveraging genomics and AI-driven systems immunology, the company designs bespoke biologics tailored to each patient’s unique immune profile. With a nimble, science-first team, it is on a mission to redefine autoimmune care and improve outcomes for individuals often underserved by one-size-fits-all treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Funding stage: Seed
- Last round: Seed (Jan 2025)
- Website: epana.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/epana-bio-192220 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.